NEDD4L and colorectal carcinoma: Moreover, NEDD4L was previously reported to inhibit CRC through suppression of the canonical WNT signaling pathway (Tanksley et al., 2013), and its expression could be targeted as either a prognostic or therapeutic biomarker (Ye et al., 2014).